kaiyun(Öйú)¹Ù·½ÍøÕ¾-¿ªÔÆÌåÓý¹Ù·½Èë¿Ú


¡¾Âö²¬Ò½Ò©¡¿MedBio|7365-44-8|2-[[Èý(ôǼ׻ù)¼×»ù]°±»ù]ÒÒ»ÇËá¼¼Êõ×ÊÁÏ

2021-03-09

2-[[Èý(ôǼ׻ù)¼×»ù]°±»ù]ÒÒ»ÇËá½á¹¹Ê½

2-[[Èý(ôǼ׻ù)¼×»ù]°±»ù]ÒÒ»ÇËáÖÐÎıðÃû£ºN-Èý(ôǼ׻ù)¼×»ù-2-°±»ùÒÒÍé»ÇËá(TES) | 3-[(ôǼ׻ù)¼×»ù°·]ÒÒÍé»ÇËá | TrisÒÒ»ÇËá,2-[(Èý(ôǼ׻ù)¼×»ù)°±»ù]-1-ÒÒ»ÇËá | N-(ôǼ׻ù)¼×»ù-2-°±»ùÒÒ»ÇËá | Èý(ôǼ׻ù)¼×°·»ùÒÒ»ÇËá | 2-[(Èý(ôǼ׻ù)¼×»ù)°±»ù]-1-ÒÒ»ÇËá | 2-[[Èý(ôǼ׻ù | N-Èý(ôǼ׻ù)¼×»ù-2-°±»ùÒÒÍé»ÇËá | TrisÒÒ»ÇËᣨTES£© | N-Èý(ôǼ׻ù)¼×»ù-2-°±»ùÒÒ»ÇËá | N-Èý(ôǼ׻ù)¼×»ù-2-°±»ùÒÒ»ÇËá | TRISÒÒ»ÇËá | 2-[£¨Èý£¨ôǼ׻ù£©¼×»ù£©°±»ù]-1-ÒÒ»ÇËá | ÈýôǼ׻ù¼×°·»ùÒÒ»ÇËá

 

1¡¢2-[[Èý(ôǼ׻ù)¼×»ù]°±»ù]ÒÒ»ÇËáÎïÀí»¯Ñ§ÐÔÖÊ£º

ÃÜ¶È 1.6¡À0.1 g/cm3
ÈÛµã ~225 ¡ãC (dec.)
·Ö×Óʽ C6H15NO6S
·Ö×ÓÁ¿ 229.25
¾«È·ÖÊÁ¿ 229.062012
PSA 135.47000
LogP -2.62
Íâ¹ÛÐÔ×´ °×É«½á¾§·ÛÄ©¡£
ÕÛÉäÂÊ 1.571
´¢´æÌõ¼þ

ÃÜ·âÓÚÒõÁ¹¸ÉÔï»·¾³¡£

Îȶ¨ÐÔ

Èç¹û×ñÕÕ¹æ¸ñʹÓúʹ¢´æÔò²»»á·Ö½â¡£

Ë®ÈܽâÐÔ SOLUBLE
·Ö×ӽṹ

1¡¢ Ħ¶ûÕÛÉäÂÊ£º48.44

2¡¢ Ħ¶ûÌå»ý£¨m3/mol£©£º147.4

3¡¢ µÈÕűÈÈÝ£¨90.2K£©£º444.0

4¡¢ ±íÃæÕÅÁ¦£¨dyne/cm£©£º82.1

5¡¢ ¼«»¯ÂÊ£¨10 -24cm 3£©£º19.20

¼ÆË㻯ѧ

1.ÊèË®²ÎÊý¼ÆËã²Î¿¼Öµ£¨XlogP£©:-5.8

2.Çâ¼ü¹©ÌåÊýÁ¿:5

3.Çâ¼üÊÜÌåÊýÁ¿:7

4.¿ÉÐýת»¯Ñ§¼üÊýÁ¿:7

5.»¥±äÒì¹¹ÌåÊýÁ¿:ÎÞ

6.ÍØÆË·Ö×Ó¼«ÐÔ±íÃæ»ý136

7.ÖØÔ­×ÓÊýÁ¿:14

8.±íÃæµçºÉ:0

9.¸´ÔÓ¶È:233

10.Í¬Î»ËØÔ­×ÓÊýÁ¿:0

11.È·¶¨Ô­×ÓÁ¢¹¹ÖÐÐÄÊýÁ¿:0

12.²»È·¶¨Ô­×ÓÁ¢¹¹ÖÐÐÄÊýÁ¿:0

13.È·¶¨»¯Ñ§¼üÁ¢¹¹ÖÐÐÄÊýÁ¿:0

14.²»È·¶¨»¯Ñ§¼üÁ¢¹¹ÖÐÐÄÊýÁ¿:0

15.¹²¼Û¼üµ¥ÔªÊýÁ¿:1

 

2¡¢2-[[Èý(ôǼ׻ù)¼×»ù]°±»ù]ÒÒ»ÇËáÓÃ;£º

TES ÓÃÓÚÖÆ×÷»º³åÈÜÒº, TES µÄ pKa ֵΪ 7.550£¬¿ÉÓÃÓÚÖÆ±¸ pH ·¶Î§Îª 6.8-8.2 µÄ»º³åÈÜÒº¡£

3¡¢2-[[Èý(ôǼ׻ù)¼×»ù]°±»ù]ÒÒ»ÇËáÉú̬ѧÊý¾Ý£º

¸ÃÎïÖʶԻ·¾³¿ÉÄÜÓÐΣº¦£¬¶ÔË®ÌåÓ¦¸øÓèÌØ±ð×¢Òâ¡£

4¡¢2-[[Èý(ôǼ׻ù)¼×»ù]°±»ù]ÒÒ»ÇËáÐÔÖÊÓëÎȶ¨ÐÔ£º

Èç¹û×ñÕÕ¹æ¸ñʹÓúʹ¢´æÔò²»»á·Ö½â¡£

5¡¢2-[[Èý(ôǼ׻ù)¼×»ù]°±»ù]ÒÒ»ÇËáÖü´æ·½·¨£º

ÃÜ·âÓÚÒõÁ¹¸ÉÔï»·¾³¡£

6¡¢2-[[Èý(ôǼ׻ù)¼×»ù]°±»ù]ÒÒ»ÇËáÎÄÏ×£º

Using promoter libraries to reduce metabolic burden due to plasmid-encoded proteins in recombinant Escherichia coli.
New Biotechnology 33 , 78-90, (2015)

A novel strategy for the discrimination of gelatinous Chinese medicines based on enzymatic digestion followed by nano-flow liquid chromatography in tandem with orbitrap mass spectrum detection.
Int. J. Nanomedicine 10 , 4947-55, (2015)

Metabolic pathway engineering using the central signal processor PII.
Microb. Cell Fact. 14 , 192, (2015)

7¡¢2-[[Èý(ôǼ׻ù)¼×»ù]°±»ù]ÒÒ»ÇËáÓ¢ÎıðÃû£º

TES
TES FREE ACID CELL CULTURE TESTED
2-{[1,3-Dihydroxy-2-(hydroxymethyl)-2-propanyl]amino}ethanesulfonic acid
TES,for biochemistry
2-[Tris(hydroxymethyl)methylamino]-1-ethanesulfonic acid
TES (buffer)
TES free acid
Taurine, N-tri(hydroxymethyl)methyl-
TES buffer
EINECS 230-906-3
TES FREE ACID SIGMAULTRA
2-{[1,3-Dihydroxy-2-(hydroxymethyl)propan-2-yl]amino}ethanesulfonic acid
Ethanesulfonic acid, 2-[[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino]-
TES,BIOLOGICALBUFFER
MFCD00007532
»õºÅ ²úÆ·Ãû³Æ Æ·ÅÆ ¹æ¸ñÐͺаü×° Ŀ¼¼Û ÊýÁ¿ ¹ºÎï³µ
MED80040 HEPES ,7365-44-8 MedBio ¡Ý98% 50g ?266.00
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿